Xcellerated T Cells

DRUG2 trials

Sponsors

Xcyte Therapies

Conditions

Multiple MyelomaNon-Hodgkin's Lymphoma

Phase 2

Xcellerated T CellsTM in Patients With Multiple Myeloma

CompletedNCT00078065

Xcyte TherapiesMultiple Myeloma

Start: 2003-11-30End: 2004-06-30Target: 30Updated: 2005-11-11

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

Xcyte TherapiesNon-Hodgkin's Lymphoma

Start: 2004-03-31Target: 40Updated: 2005-06-24